MANAGEMENT OF PCP Dr. Akaninyene A. Otu, MBBCh, DTM&H, MPH, MRCP (UK), FWACP University of Calabar Teaching Hospital Calabar, Nigeria.

Slides:



Advertisements
Similar presentations
Realities in the field FEVER Differential Diagnosis not possible What happens in practice when a child presents with fever Where malaria risk is high.
Advertisements

SEPSIS KILLS program Paediatric Inpatients
Doug Simkiss Associate Professor of Child Health Warwick Medical School Management of sick neonates.
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
Pneumonia Sapna Bamrah, MD CDC
Severe pneumonia in childhood. Robert Gie Department Paediatrics and Child Health Stellenbosch University.
Department of Child and Adolescent Health and Development Identifying topics on TB treatment for literature review In collaboration with International.
Acute severe asthma.
IMCI Dr. Bulemela Janeth (Mmed. Pead) 1IMCI for athens.
Integrated Management of Childhood Illnesses (IMCI) Dr. Pushpa Raj Sharma DCH, DTCH, FCPS Professor of Child Health Institute of Medicine, Kathmandu, Nepal.
Pneumonia diagnosis and treatment Prognosis for severe disease.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
Institute of Child Health
Special care of preterm babies
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
Pneumonia in Immunocompromised Host:- Pneumonia in an immunocompromised host describes a lung infection that occurs in a person whose ability to fight.
Approach To Pneumonia. Pneumonia Importance Mechanism Classification & its benefit Diagnosis Treatment.
MANAGEMENT FOR PAEDIATRIC PATIENT UNDER INVESTIGATION (PUI) WITH INFLUENZA-LIKE ILLNESS (ILI) IN OUTPATIENT SETTING CM CHOO HSAH 2013.
Pneumonia Name Dr J Mackintosh & Dr J Thurlow Date 18/11/2014
1 Exploring Alternative Antibiotic Treatment Regimens: Methodology and Implications Dr. Tabish Hazir MASCOT Study Group 2 nd ICIUM Conference 2004.
TREATMENT OF SEVERE PNEUMONIA WITH ORAL ANTIBIOTICS Lozano JM, on behalf of the APPIS Trial Group. Department of Pediatrics and Clinical Epidemiology Unit,
Indiaclen Short course of Amoxicillin in treatment of Pneumonia (ISCAP) 3 versus 5 days amoxicillin for treatment of non-severe pneumonia in young children:
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
Integrated Management of Childhood Illnesses
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
PAEDIATRIC NURSING 2 10CREDITS.
1 Recent Advances in Provision of Primary Care in the Public Sector: Is 3 Days of Oral Antibiotic Therapy Enough for Treatment of Ambulatory Pneumonia?
COSTS STUDY OF SEVERE PNEUMONIA IN AN EQUIVALENCE TRIAL OF ORAL AMOXICILLIN VERSUS INJECTABLE PENICILLIN IN CHILDREN AGED 3 TO 59 MONTHS Patel AB, APPIS.
Three days vs five days oral cotrimoxazole therapy in non-severe pneumonia Kartasasmita C, Samir K. Saha * and Cotrimoxazole Study Group Indonesia and.
Integrated Management of Childhood Illnesses (IMCI) Dr. Pushpa Raj Sharma DCH, DTCH, FCPS Professor of Child Health Institute of Medicine, Kathmandu, Nepal.
R3 정수웅. Introduction Community-acquired pneumonia − Leading infectious cause of death in developed countries − The mortality in patients with treatment.
LSU Journal Club Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia A Systematic Review and Meta-analysis Scott Hebert,
Antibiotics In Respiratory Infection To Use or Not to Use - that is the question. Dr. James Paton University of Glasgow.
BRONCHIOLITIS Dr Jonny Taitz, FRACP Geschn Paediatrician Sept 2003.
EBM Journal Club GS 謝閔傑. 題目 對於治療急性壞死性胰臟炎病患有需要使用抗生 素治療嗎?
Fekri Abroug, Lamia Ouanes-Besbes, Mohamed Fkih-Hassen, Islem Ouanes, Samia Ayed, Laurent Brochard and Souheil ElAtrous Prednisone in COPD exacerbation.
ALC, Pneumonia, COPD, Strokes
ACUTE RESPIRATORY INFECTION
CDiC Programme Introduction.
Evaluation and Treatment of Children with Bronchiolitis in the Emergency Department Suspected bronchiolitis: Otherwise healthy child < 24 months of age.
Ari control and prevention
Research where it is most needed National Respiratory Strategy
Acute respiratory infections (ARI)
Correlation of developmental outcome with severity of bronchopulmonary dysplasia in extremely low gestational age neonates Karen Belen, Chengqiu Lu, Narges.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Primary-Secondary Care Partnership in Treatment of Severe Cellulitis
Evaluation and Treatment of Children with Bronchiolitis in the Emergency Department Suspected bronchiolitis: Otherwise healthy child < 24 months of age.
The use of cotrimoxazole prophylaxis in the context of HIV infection
WHO recommendations on interventions to improve preterm birth outcomes
PCP in adults: Presentation , Treatment and Prophylaxis
Assessment of Hypoxaemia
COPD Exacerbations UCI Internal Medicine Mini-Lecture
PCP: Clinical Presentation
PCP: management of co-infection
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
PCP in adults: Presentation , Treatment and Prophylaxis
Assessment of Hypoxaemia
Recognising sepsis and taking action
PCP: Clinical Presentation
PCP: management of co-infection
Dr Immaculate Kariuki Consultant Paediatrician Nairobi, Kenya
Bacterial meningitis was uniformly lethal up to the introduction of antimeningococcal antisera in the early 20th century In 1940, mortality rates were.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
BY ABDULJALEEL ELSHALWI MAHMOUD ELMABRI ANTIBIOTICS PROTOCOLS IN A NEONATAL INTENSIVE CARE UNITE OF AL-WAHDA HOSPITAL DERNA.
Anthony D Harries Ministry of Health, Malawi
Chapter 4 Cough or difficult breathing Case I
City and Hackney Bronchiolitis Pathway
Empiric antibiotic therapy
Shortness of breath & the child with wheeze
Presentation transcript:

MANAGEMENT OF PCP Dr. Akaninyene A. Otu, MBBCh, DTM&H, MPH, MRCP (UK), FWACP University of Calabar Teaching Hospital Calabar, Nigeria

Objectives To be aware of the criteria for admission of patients with PCP To understand the grading of PCP severity To understand the options available for treatment To understand the role of steroids in management of PCP

Oxygen therapy and respiratory support Nutrition PCP treatment Introduction Admission Oxygen therapy and respiratory support Nutrition PCP treatment Complications Treatment of co-infections

Admission: WHO recommendations All HIV infected children with severe pneumonia should be admitted due to increased risk of deterioration Admit children with very severe pneumonia for nutrition, oxygen & monitoring Recap of the WHO classifications in the next slide

How severe is respiratory distress – Cough or Difficult Breathing? Cyanosed or oxygen saturation <90%? Unable to drink? Reduced level of consciousness? Grunting ? Y Severe Pneumonia Lower chest wall indrawing? OR Fast breathing? (RR ≥ 50 ages 2 –11 months RR ≥ 40 ages 12 – 59 months Y Pneumonia As a result of this research the WHO proposes a classification of pneumonia based on key signs – this is part of the IMCI (and previously the ARI) programme. Working from the severe end downwards one can check for only a few signs in a child with cough and difficulty breathing and classify into one of four categories that provide a measure of the severity of the child’s disease. Once the severity is classified it becomes easier to decide who should be in hospital – only those with severe pneumonia. There is evidence that this classification works to identify those at greatest risk of death and thus most in need of hospital care (see pneumonia severity of disease summary). Syndromic classification – based on the clinical signs In the 4th Edition Basic Paediatric Protocol pneumonia is simply classified into 2 classification on if there are danger signs or not If there are danger signs then that is Severe pneumonia If not danger signs then its is ‘pneumonia ‘–non severe. Thus patients who have in-drawing OR fast breathing with danger signs is classified as PNEUMONIA Y None of the above? No Pneumonia

Grading of PCP severity Mild Defined as having both PaO2 ≥70 mmHg and A-a gradient of≤ 35 mmHg at room air Antibiotics can be administered either intravenously or orally Adapted from best practice bmj http://bestpractice.bmj.com/best-practice/monograph/19/treatment/step-by-step.html

Grading of PCP severity Moderate-severe PaO2 of <70 mmHg or an A-a gradient >35 mmHg at room air Children should be hospitalised. Admission to an intensive care unit or mechanical ventilation may be required Antibiotics given intravenously if available Addition of steroids is necessary

Therapy COTRIMOXAZOLE (COTRIM) Can use IV initially for 3-10 days 20mg/kg/day in 4 divided doses based on the trimethoprim component Used even for children on cotrim prophylaxis as PCP breakthrough usually related to non-adherence (not resistance Watch for hypersensitivity Needs adjusting for renal failure

Alternative therapy Clindamycin at 10mg/kg/ dose every 6 hours combined with primaquine at 0.3mg/kg/day of the base is another alternative. Caution in G6PDH deficiency (no evidence for paediatrics) IV pentamidine 4mg/kg/day if cannot tolerate cotrim or not improving after 5-7 days of cotrim Trimethoprim and dapsone (all oral) for mild cases (no evidence for paediatrics)

Steroids Indicated in moderate & severe disease Reduces mortality and need for mechanical ventilation No clear role in non HIV PCP Commonly used regimen- oral prednisone 2mg/kg/day x 5 days, 1mg/kg/day x 5 days, 0.5mg/kg/day x 11 days References: Bye et al. Markedly Reduced Mortality Associated With Corticosteroid Therapy of Pneumocystis carinii Pneumonia in Children With Acquired Immunodeficiency Syndrome Arch Pediatr Adolesc Med. 1994;148(6):638-641. ii) Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in patients with HIV infection. [Cochrane Database Syst Rev. 2006 Newberry L et al .Early use of steroids in infants with a clinical diagnosis of PCP in Malawi: a double-blind RCT

Summary Admission criteria used in managing all-cause childhood pneumonia may be used for PCP as well Cotrimoxazole is the first line of treatment of PCP The grading of severity of PCP is crucial in determining route of antimicrobial administration and addition of steroids Steroid use is associated with reduction of mortality and need for mechanical ventilation

END